Johnson B F, LaBrooy J, Munro-Faure A D
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):783-7.
1 The interaction of phentolamine with the beta-adrenoreceptor-blocking drug, oxprenolol, was studied in a controlled trial. 2 The combination was generally well tolerated. 3 Oxprenolol alone produced modest but significant reductions in supine, standing and post-exercise blood pressures. Small reductions were observed only with sustained phentolamine administration. 4 The combined effect of the two drugs seemed to be addictive only at the lower level of oxyprenolol dosage. 5 Labetalol produced significantly greater reductions in supine and standing blood pressure than combined oxprenolol-phentolamine. At a daily dose of 400 mg, postural hypotension was not observed, although transient symptoms were frequent.
1 在一项对照试验中研究了酚妥拉明与β-肾上腺素受体阻滞剂氧烯洛尔的相互作用。2 该组合一般耐受性良好。3 单独使用氧烯洛尔可使仰卧位、站立位及运动后血压适度但显著降低。仅持续给予酚妥拉明时观察到小幅降低。4 两种药物的联合作用似乎仅在较低剂量的氧烯洛尔时具有相加性。5 拉贝洛尔比氧烯洛尔-酚妥拉明联合用药能更显著地降低仰卧位和站立位血压。每日剂量为400毫克时,虽常有短暂症状,但未观察到体位性低血压。